On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Beau R. Webber

ResearcherPublications, citations & collaboration network

Beau R. Webber is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Beau R. Webber have?

ScholarIQindexed works

Beau R. Webber has 146 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Beau R. Webber have?

ScholarIQcitation count

Beau R. Webber has 3,736 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Beau R. Webber?

ScholarIQh-index

Beau R. Webber has an h-index of 28 in OpenAlex.

What is the i10-index of Beau R. Webber?

ScholarIQi10-index

Beau R. Webber has an i10-index of 53 in OpenAlex.

What is the ORCID of Beau R. Webber?

ScholarIQorcid

The ORCID for Beau R. Webber is on the source record.

What is the OpenAlex record for Beau R. Webber?

ScholarIQopenalex

The OpenAlex for Beau R. Webber is on the source record.

What are the most-cited papers on Beau R. Webber?

ScholarIQmost cited works
EditR: A Method to Quantify Base Editing from Sanger Sequencing
Mitchell G. Kluesner, Derek Nedveck, Walker S. Lahr, John Garbe, Juan E. Abrahante, Beau R. Webber, Branden S. Moriarity
The CRISPR Journal. 2018648 CitationsOPEN ACCESS
TALEN-based Gene Correction for Epidermolysis Bullosa
Mark J. Osborn, Colby G. Starker, Amber McElroy, Beau R. Webber, Megan Riddle, Lily Xia, Anthony P. DeFeo, Richard Gabriel, Manfred Schmidt, Christof von Kalle, Daniel F. Carlson, Morgan L. Maeder, J. Keith Joung, John E. Wagner, Daniel F. Voytas, Bruce R. Blazar, Jakub Tolar
Molecular Therapy. 2013257 CitationsOPEN ACCESS
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
Beau R. Webber, Cara-lin Lonetree, Mitchell G. Kluesner, Matthew J. Johnson, Emily J. Pomeroy, Miechaleen D. Diers, Walker S. Lahr, Garrett M. Draper, Nicholas J. Slipek, Branden A. Smeester, Klaus N. Lovendahl, Amber McElroy, Wendy R. Gordon, Mark J. Osborn, Branden S. Moriarity
Nature Communications. 2019229 CitationsOPEN ACCESS
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Mark J. Osborn, Beau R. Webber, Friederike Knipping, Cara-lin Lonetree, Nicole Tennis, Anthony P. DeFeo, Amber McElroy, Colby G. Starker, Catherine Lee, Sarah C. Merkel, Troy C. Lund, Karen S. Kelly‐Spratt, Michael C. Jensen, Daniel F. Voytas, Christof von Kalle, Manfred Schmidt, Richard Gabriel, Keli L. Hippen, Jeffrey S. Miller, Andrew M. Scharenberg, Jakub Tolar, Bruce R. Blazar
Molecular Therapy. 2015201 CitationsOPEN ACCESS
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
Emily J. Pomeroy, John Hunzeker, Mitchell G. Kluesner, Walker S. Lahr, Branden A. Smeester, Margaret R. Crosby, Cara-lin Lonetree, Kenta Yamamoto, Laura E. Bendzick, Jeffrey S. Miller, Melissa A. Geller, Bruce Walcheck, Martin Felices, Beau R. Webber, Timothy K. Starr, Branden S. Moriarity
Molecular Therapy. 2019187 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial